EUVIMEDEUVIMED entdecken
Crossref

Nebulized pH-Responsive Nanospray Combined with Pentoxifylline and Edaravone to Lungs for Efficient Treatments of Acute Respiratory Distress Syndrome

Ruihao Li, Xiaochun Hu, Wenhui Li, Wenjing Wu, Jin Xu, Yun Lin, Shuo Shi iD, Chunyan Dong

ACS Applied Materials & Interfaces · 2024

DOI: 10.1021/acsami.3c15691 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2024. Verfasst von Ruihao Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Comprehensive Cancer Therapy, Shanghai East Hospital, School of Medicine, Shanghai Key Laboratory of Chemical Assessment and Sustainabi…. Hauptthemen laut MEDLINE: Pentoxifylline, Respiratory Distress Syndrome, COVID-19. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai Municipality, Science and Technology Commission of Shanghai Municipality, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID-19 pandemic has become an unprecedented global medical emergency, resulting in more than 5 million deaths. Acute respiratory distress syndrome (ARDS) caused by COVID-19, characterized by the release of a large number of pro-inflammatory cytokines and the production of excessive toxic ROS, is the most common serious complication leading to death. To develop new strategies for treating ARDS caused by COVID-19, a mouse model of ARDS was established by using lipopolysaccharide (LPS). Subsequently, we have constructed a novel nanospray with anti-inflammatory and antioxidant capacity by loading pentoxifylline (PTX) and edaravone (Eda) on zeolite imidazolate frameworks-8 (ZIF-8). This nanospray was endowed with synergetic therapy, which could kill two birds with one stone: (1) the loaded PTX played a powerful anti-inflammatory role by inhibiting the activation of inflammatory cells and the synthesis of pro-inflammatory cytokines; (2) Eda served as a free radical scavenger in ARDS. Furthermore, compared with the traditional intravenous administration, nanosprays can be administered directly and inhaled efficiently and reduce the risk of systemic adverse reactions greatly. This nanospray could not only coload two drugs efficiently but also realize acid-responsive release on local lung tissue. Importantly, ZIF8-EP nanospray showed an excellent therapeutic effect on ARDS in vitro and in vivo, which provided a new direction for the treatment of ARDS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PentoxifyllineRespiratory Distress SyndromeCOVID-19AnimalsMiceHumansEdaravonePandemicsLungAnti-Inflammatory AgentsCytokinesHydrogen-Ion ConcentrationLipopolysaccharides

Stichwörter der Autor:innen

ARDSCOVID-19edaravonenanospraypentoxifylline

Substanzen

PentoxifyllineEdaravoneAnti-Inflammatory AgentsCytokinesLipopolysaccharides

Autor:innen und Institutionen

  • Department of Comprehensive Cancer Therapy, Shanghai East Hospital, School of Medicine, Shanghai Key Laboratory of Chemical Assessment and Sustainability, School of Chemical Science and Engineering, Tongji University, S…
  • School of Medicine, Shanghai University, Shanghai 200444, P. R. China.
  • Shanghai Institute of Quality Inspection and Technical Research, Shanghai 201100, P. R. China.

ORCID-Profile: Shuo Shi

Förderung

  • Natural Science Foundation of Shanghai Municipality
  • Science and Technology Commission of Shanghai Municipality
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • the Industry Special Project of Shanghai Pudong New Area Health and Family Planning Commission
  • Foundation of Chinese Society of Clinical Oncology
  • the Shanghai Pudong New Area Health and Family Planning Commission Leading Talent Training Program

Zitieren

APA

Li, R., Hu, X., Li, W., Wu, W., Xu, J., Lin, Y., Shi, S., & Dong, C. (2024). Nebulized pH-Responsive Nanospray Combined with Pentoxifylline and Edaravone to Lungs for Efficient Treatments of Acute Respiratory Distress Syndrome. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.3c15691

Vancouver

Li R, Hu X, Li W, Wu W, Xu J, Lin Y, et al. Nebulized pH-Responsive Nanospray Combined with Pentoxifylline and Edaravone to Lungs for Efficient Treatments of Acute Respiratory Distress Syndrome. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.3c15691

BibTeX
@article{Li2024,
  author = {Li, Ruihao and Hu, Xiaochun and Li, Wenhui and Wu, Wenjing and Xu, Jin and Lin, Yun and Shi, Shuo and Dong, Chunyan},
  title = {Nebulized pH-Responsive Nanospray Combined with Pentoxifylline and Edaravone to Lungs for Efficient Treatments of Acute Respiratory Distress Syndrome},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  doi = {10.1021/acsami.3c15691}
}
Kostenlos starten →